Mayport LLC’s BeOne Medicines Ltd ONC Stock Holding History

Mayport LLC’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,089	Closed	-$205K	–	63
2022 Q1	$205K	Hold	1,089	–	–	0.14%	59
2021 Q4	$295K	Buy	+1,089	New	+$368K	0.22%	48

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Mayport LLC's ONC Position: Q2 2022 in Review

Mayport LLC sold out of BeOne Medicines Ltd (ONC) in Q2 2022, closing a stake of 1,089 shares — an estimated $205K sold.

Mayport LLC first reported a position in ONC in Q4 2021 and held it in 2 quarters. The position peaked at $295K in Q4 2021. 234 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

Mayport LLC reported no remaining BeOne Medicines Ltd position as of Q2 2022 after selling out during the quarter.
Mayport LLC sold 1,089 BeOne Medicines Ltd shares in Q2 2022, an estimated $205K.
Mayport LLC first reported a position in BeOne Medicines Ltd in Q4 2021 and held it in 2 quarters.
Mayport LLC's BeOne Medicines Ltd position peaked at $295K in Q4 2021.
234 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Mayport LLC's 13F filing for Q2 2022, filed 15 Jul 2022.